2023
DOI: 10.52711/0974-360x.2023.00152
|View full text |Cite
|
Sign up to set email alerts
|

Docking Study, ADMET Profiling of the Designed 3-Chlorobenzo[b]thiophene-2-Carbonyl Chloride Derivatives: Promising Anti-Breast Cancer Activity

Abstract: Globally, breast cancer accounted for approximately 700٫000 deaths in 2020. Estrogen receptor alpha (ERα) is the primary pathway for breast cancer treatment. Tamoxifen (TAM) is the most extensively used drug for estrogen receptor (+) breast cancer. However, it is implicated in endometrial carcinoma, pulmonary thrombus, stroke, and breast cancer resistance. This research aims to overcome these issues in selectivity and side effects. The study was conducted in a new drug design using Structure Based Drug Design … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 35 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?